G
Genezen
A contract development and manufacturing organization (CDMO) specializing in viral vectors for gene and cell therapies
About Genezen
A contract development and manufacturing organization (CDMO) specializing in the gene and cell therapy sector. The company provides services for the development and manufacturing of viral vectors, which are essential components in gene and cell therapies.
Its offerings cover a wide range of activities, from process development for viral vectors to the production of GMP-grade vectors for clinical trials. Genezen also provides services for transduced cell manufacturing and analytical testing. The company serves biotech and pharmaceutical companies worldwide that are developing gene and cell therapies.
The business model is based on providing fee-for-service solutions to its clients, supporting them from the early stages of development to clinical manufacturing. By focusing on the manufacturing and development aspects, Genezen enables its clients to advance their therapeutic programs.
Source: Dealroom company dataAt a glance
- Founded
- 2014
- Headquarters
- Lexington, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Ampersand Capital Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Genezen on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Genezen on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.